Home › Funds › NEXTBio Capital Management LP › COGT

NEXTBio Capital Management LP position in COGT

COGENT BIOSCIENCES INC · Health Care

NEXTBio Capital Management LP reported holding 178,036 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.7M, representing 2.48% of its reported portfolio and ranking #17 among its reported holdings. NEXTBio Capital Management LP has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)178.04K sh
Reported value held$5.70M
Portfolio Weight2.48%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's COGT position evolved

NEXTBio Capital Management LP first disclosed a stake in COGT in Q4 2025 at 95,819 shares (US$3.4M). The position peaked in Q3 2026 at 178,036 shares, worth US$5.7M. Across 4 filings, NEXTBio Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 178,036 shares valued at US$5.7M — an increase of 46,961 shares quarter over quarter.. Notable position changes include a 37% increase in Q1 2026 (shares were roughly flat over the following quarter), a 36% increase in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 95.82K $3.40M New
Q1 2026 131.19K $5.05M Add
Q2 2026 131.07K $5.07M Hold
Q3 2026 178.04K $5.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has NEXTBio Capital Management LP held COGT?

NEXTBio Capital Management LP has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NEXTBio Capital Management LP's current position in COGT?

As of Q3 2026, NEXTBio Capital Management LP holds 178.04K shares of COGT (COGENT BIOSCIENCES INC), valued at $5.70M, representing 2.48% of its reported portfolio and ranking #17.

Has NEXTBio Capital Management LP been buying or selling COGT?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP increased its position in COGT. The position peaked in Q3 2026 at 178.04K shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.